Lijun International Pharmaceutical (Holding) Co., Ltd. is an investment holding company. The Company, along with its subsidiaries, is engaged in the research, development, manufacturing and selling of a range of finished medicines and bulk pharmaceutical products to hospitals and distributors. The Company has manufacturing plants in Hebei Province and Shaanxi Province, the People�s Republic of China and sells to customers principally in Mainland China. The Company�s segments include intravenous infusion solution, and antibiotics and others. Its subsidiaries include New Orient Investments Limited, Shijiazhuang No.4 Pharmaceutical Co., Ltd., Xi�an Lijun Pharmaceutical Co., Ltd., Shenzhen Lijun Pharmaceutical Co., Ltd., HebeiJinmen PharmaceuticalImport&ExportCo.,Ltd., HebeiGuolong PharmaceuticalCo.,Ltd. and others.